Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in the Prevention of Vasovagal Syncope
NCT01456481Phase 4Active, not recruiting
- Start
- Nov 2011
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of midodrine in vasovagal syncope. Started Nov 2011; status: active, not recruiting.
02
Drugs
midodrine
03
Conditions
vasovagal syncope
Beyond the preview
Go deeper on NCT01456481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456481.